Breaking News
Ipsen acquires Memo Therapeutics for up to $800 million
Biotech Biotech Headlines

Ipsen acquires Memo Therapeutics for up to $800 million

Source: news.google.com

Published: Jul 01, 2026 12:53

Read Original Source
Ipsen acquires Memo Therapeutics for up to $800 million  qz.com
Detailed source content is still being fetched from the original article. Use the source link above for the live story.

Related Stories

More from this topic and section

Add Shortcut

Add Newsfeed to your home screen

Open this site faster like an app from your phone home screen.

X in 3s